Precision Therapeutics, Inc. was founded in 1995 to help physicians determine and individualize the most appropriate cancer treatments for their patients.
Precision Therapeutics evaluates how tumor cells cultured from a patient's cancer specimen respond to anticancer drug and radiation therapies. The results provide physicians with unique, patient-specific tumor information.
Precision Therapeutics can further characterize tumor cell biology with its additional tumor analysis tests. Its scientific staff has extensive experience in clinical testing and cancer research and is committed to offering clinically relevant, quantitative and timely services to physicians and their patients, and to pharmaceutical and biotechnology companies.
Additionally, the company's Pharmaceutical Services Program can support pharmaceutical and biotechnology companies in the development and discovery of new cancer therapies.